Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 1.52%8.89B | ---- | ---- | ---- | 31.47%8.75B | ---- | ---- |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | -1,217.95%-57.41M | ---- | ---- | ---- | 25.46%-4.36M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | 388.79%1.07B | ---- | ---- | ---- | 36.07%218.75M | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -69.78%23.15M | ---- | ---- | ---- | --76.62M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 635.98%1.05B | ---- | ---- | ---- | -11.59%142.13M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -23.32%-202.89M | ---- | ---- | ---- | -255.74%-164.52M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -23.32%-202.89M | ---- | ---- | ---- | -255.74%-164.52M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | 3,958.33%189.73M | ---- | ---- | ---- | 116.65%4.68M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 291.76%10.52M | ---- | ---- | ---- | 92.12%-5.49M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 1,400.00%152.4M | ---- | ---- | ---- | -75.53%10.16M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | --26.81M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 5.15%3.02B | ---- | ---- | ---- | 7.66%2.88B | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | 5.15%3.02B | ---- | ---- | ---- | 7.66%2.88B | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 119.17%17.93M | ---- | ---- | ---- | 36.48%-93.54M | ---- | ---- |
| Special items | ---- | ---- | ---- | 44.24%653.75M | ---- | ---- | ---- | 3.90%453.23M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 12.77%13.58B | ---- | ---- | ---- | 24.18%12.04B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -184.21%-10.5M | ---- | ---- | ---- | -56.96%12.46M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -283.20%-875.29M | ---- | ---- | ---- | 455.19%477.77M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -122.82%-125.53M | ---- | ---- | ---- | -31.20%550.12M | ---- | ---- |
| Advance payment increase (decrease) | ---- | ---- | ---- | -148.67%-180.58M | ---- | ---- | ---- | 150.46%371.04M | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | 29.63%-510.79M | ---- | ---- | ---- | -332.02%-725.85M | ---- | ---- |
| Cash from business operations | ---- | ---- | ---- | -6.68%11.88B | ---- | ---- | ---- | 20.16%12.73B | ---- | ---- |
| Other taxs | ---- | ---- | ---- | 42.64%155.63M | ---- | ---- | ---- | -19.71%109.11M | ---- | ---- |
| Special items of business | -10.22%7.74B | -17.78%4.53B | 16.34%2.36B | -215.77%-604.82M | -8.63%8.62B | -15.21%5.51B | -25.82%2.03B | -30.30%522.42M | 22.42%9.44B | 33.02%6.5B |
| Net cash from operations | -10.22%7.74B | -17.78%4.53B | 16.34%2.36B | -14.46%11.43B | -8.63%8.62B | -15.21%5.51B | -25.82%2.03B | 16.39%13.36B | 22.42%9.44B | 33.02%6.5B |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---- | 105.82%322K | ---- | -68.79%31.97M | ---- | -105.16%-5.53M | ---- | 529.26%102.46M | ---- | 556.78%107.1M |
| Sale of fixed assets | ---- | ---- | ---- | 14.48%164.37M | ---- | ---- | ---- | 27.12%143.58M | ---- | ---- |
| Purchase of fixed assets | ---- | -10.53%-2.93B | ---- | 20.23%-5.21B | ---- | 40.48%-2.65B | ---- | 7.62%-6.53B | ---- | -37.11%-4.45B |
| Purchase of intangible assets | ---- | 54.53%-146.5M | ---- | -392.36%-693.97M | ---- | -483.24%-322.23M | ---- | 59.14%-140.95M | ---- | 40.61%-55.25M |
| Sale of subsidiaries | ---- | ---- | ---- | -105.05%-3.18M | ---- | ---- | ---- | -72.70%63M | ---- | ---- |
| Recovery of cash from investments | ---- | -6.77%6.83B | ---- | 12.76%17.43B | ---- | 53.14%7.33B | ---- | 117.80%15.46B | ---- | 88.50%4.79B |
| Cash on investment | ---- | 28.55%-8.22B | ---- | 17.09%-17.7B | ---- | -14.42%-11.51B | ---- | -33.06%-21.35B | ---- | -66.56%-10.06B |
| Other items in the investment business | 46.97%-4.75B | 28.79%139.38M | -32.78%-3.16B | ---- | 33.34%-8.96B | -58.20%108.22M | 59.45%-2.38B | ---- | -15.20%-13.43B | 500.09%258.92M |
| Net cash from investment operations | 46.97%-4.75B | 38.65%-4.32B | -32.78%-3.16B | 51.19%-5.98B | 33.34%-8.96B | 25.12%-7.04B | 59.45%-2.38B | 23.62%-12.25B | -15.20%-13.43B | -35.87%-9.41B |
| Net cash before financing | 1,001.72%2.99B | 113.64%209.2M | -128.83%-795.49M | 391.67%5.45B | 91.69%-331.99M | 47.27%-1.53B | 88.89%-347.63M | 124.29%1.11B | -1.13%-4B | -42.70%-2.91B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -7.74%10.67B | ---- | 60.54%19.71B | ---- | 95.51%11.56B | ---- | 60.09%12.28B | ---- | 28.70%5.91B |
| Refund | ---- | -0.11%-8.95B | ---- | -81.02%-17.97B | ---- | -93.27%-8.94B | ---- | -68.68%-9.92B | ---- | -344.38%-4.62B |
| Dividends paid - financing | ---- | 42.91%-2.06B | ---- | -170.47%-5.61B | ---- | -73.72%-3.6B | ---- | -56.63%-2.07B | ---- | -58.37%-2.07B |
| Absorb investment income | ---- | 38.16%2.85M | ---- | 5.14%20.34M | ---- | 6.74%2.06M | ---- | -92.99%19.35M | ---- | -98.99%1.93M |
| Issuance expenses and redemption of securities expenses | ---- | ---46.56M | ---- | -15.01%-1.16B | ---- | ---- | ---- | -1,087.20%-1.01B | ---- | ---287.84M |
| Other items of the financing business | -631.85%-7.05B | ---- | -300.64%-261.09M | ---- | -168.99%-963.31M | ---- | -84.52%130.13M | -401.17%-64.71M | -84.07%1.4B | -393.19%-64.81M |
| Net cash from financing operations | -631.85%-7.05B | 61.09%-378.8M | -300.64%-261.09M | -548.86%-5B | -168.99%-963.31M | 14.13%-973.49M | -84.52%130.13M | -110.91%-769.84M | -84.07%1.4B | -146.78%-1.13B |
| Effect of rate | -530.51%-52.16M | -191.99%-32.27M | -132.54%-12.56M | -76.23%26.11M | -107.85%-8.27M | -63.44%35.08M | 531.95%38.6M | -67.51%109.84M | -73.47%105.39M | -44.49%95.93M |
| Net Cash | -213.17%-4.06B | 93.24%-169.6M | -385.78%-1.06B | 34.03%453.53M | 50.18%-1.3B | 37.97%-2.51B | 90.49%-217.5M | -86.44%338.38M | -154.01%-2.6B | -1,149.16%-4.04B |
| Begining period cash | 3.68%13.53B | 3.68%13.53B | 3.68%13.53B | 3.56%13.05B | 3.56%13.05B | 3.56%13.05B | 3.56%13.05B | 29.01%12.6B | 29.01%12.6B | 29.01%12.6B |
| Cash at the end | -19.79%9.42B | 25.99%13.33B | -3.19%12.46B | 3.68%13.53B | 16.22%11.75B | 22.21%10.58B | 24.90%12.87B | 3.56%13.05B | -32.52%10.11B | -16.18%8.66B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.